CLINICAL_TRIALS ClinicalTrials.gov record update

A Study to Provide Expanded Access of (Exjade®) Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload From Blood Transfusions Who Cannot Adequately be Treated With Other Locally Approved Iron Chelators

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00235391
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:10.017023+00:00
Published At: 2011-05-02T00:00:00+00:00
Record Updated At: 2011-06-07
Results Posted At: 2011-05-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Thalassemia", "Sickle Cell Disease", "Diamond Blackfan Anemia", "Myelofibrosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2011-06-07"
protocolSection.identificationModule.nctId: "NCT00235391"
protocolSection.identificationModule.officialTitle: "A Study to Provide Expanded Access of (Exjade\u00ae) Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload From Blood Transfusions Who Cannot Adequately be Treated With Other Locally Approved Iron Chelators"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2011-05-02"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.